The Federal Circuit Weighs in On Hatch-Waxman "Skinny" Label Infringement Dispute | Fish & Richardson
The Hatch-Waxman Act allows a generic drugmaker to rely on a branded drugmaker’s Food and Drug Administration-approved New Drug Application if the generic drugmaker can show that the...
Source: jdsupra.com